Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Grants Orphan Drug Designation for Retrotope's RT001 in the Treatment of Phospholipase 2G6 (P… November 1, 2017 <b>OZMOSI</b> Launches A Global Clinical Trials Database To Transform Drug Development Forecasting September 10, 2017 New SoCal Biotech Makes Debut and Will Take on NASH February 14, 2017
FDA Grants Orphan Drug Designation for Retrotope's RT001 in the Treatment of Phospholipase 2G6 (P… November 1, 2017
<b>OZMOSI</b> Launches A Global Clinical Trials Database To Transform Drug Development Forecasting September 10, 2017